Chad Deal, M.D.
| Appointed: |
1999 |
| Gender: |
Male |
| Languages: |
English |
Rheumatologic and Immunologic Disease
Rheumatologic and Immunologic Disease
Biographical Sketch
Chad Deal, MD, is Head of the Center for Osteoporosis and Metabolic Bone Disease and a board-certified Rheumatologist at Cleveland Clinic, Cleveland, Ohio. He has specialty interests in osteoporosis and related conditions. Dr. Deal did his undergraduate work at Washington University, St. Louis, Mo. He attended medical school at the University of Arkansas, was inducted into Alpha Omega Alpha, and graduated in 1977. His internship and residency were at Boston City Hospital in Boston, Mass. He completed a fellowship in arthritis and connective tissue diseases at Boston University School of Medicine in 1982.
Dr. Deal has been in Cleveland since 1984. He was Associate Professor of Medicine at the Case Western Reserve University School of Medicine until 1999, when he left to become Head of the Center for Osteoporosis and Metabolic Bone Disease at Cleveland Clinic.
Dr. Deal has been an active investigator in multiple clinical trials relating to arthritis and osteoporosis. He has been an investigator in numerous multicenter trials, including drug trials using teriparatide (PTH) with raloxifene, zoledronic acid after teriparatide, and novel anabolic agents. He is author of over 50 publications.
He is a past member on the Committees on Rheumatologic Care, Training and Workforce, and Finance for the American College of Rheumatology. He is currently on the Board of Directors of the American College of Rheumatology. He is a member of the Interspecialty Medical Council of the NOF for the ACR. Dr. Deal is a reviewer for numerous rheumatology, orthopedic and osteoporosis journals. He has received the National Volunteer Service Citation from the Arthritis Foundation, and has been awarded Teacher of the Year in Rheumatic Diseases at Cleveland Clinic. He has been named one of the best doctors in Cleveland.
Professional Highlights
- Board of Directors, American College of Rheumatology
Education & Fellowships
| Medical School: | University of Arkansas College of Medicine, Little Rock, AR |
|
| Internship: | Boston Medical Center, Internal Medicine, Boston, MA |
| Residency: | Boston Medical Center, Internal Medicine, Boston, MA |
| Fellowship: | Boston Medical Center, Rheumatology, Boston, MA |
| Other Education: | (Undergraduate) Washington University, St. Louis, MO |
Certifications
Rheumatology
Internal Medicine
Specialty Interests
Arthritis, connective tissue disease, Metabolic Bone Disease, Osteoporosis.
Awards & Honors
Best Doctor, Cleveland magazine
Professional Memberships
- American College of Rheumatology
- American Society of Bone and Mineral Research
- International Society of Clinical Densitometry
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 10/15/2008, Dr. Deal has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Deal receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
- Eli Lilly and Company
- GlaxoSmithKline
- Novartis
- Procter & Gamble
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
